Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307343405> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4307343405 endingPage "158" @default.
- W4307343405 startingPage "152" @default.
- W4307343405 abstract "The aim of this study was to examine the safety and the effect of severe renal impairment (RI) on the pharmacokinetics of ACT-1014-6470, a novel oral complement factor 5a receptor 1 antagonist. A phase 1 single-center, open-label, single-dose, parallel-group study was conducted in subjects with severe RI (n = 8) compared to demographically pairwise matched subjects with normal renal function (n = 8). Plasma levels of ACT-1014-6470 were measured up to 120 hours following an oral 40-mg dose. Safety evaluations included adverse events (AEs), vital signs, hematology, coagulation, clinical chemistry tests, and electrocardiograms. All 16 subjects completed the study. Relative to subjects with normal renal function, ACT-1014-6470 time to maximum plasma concentration was delayed with a median of differences of 3 hours. The maximum plasma concentration and the area under the plasma concentration-time profile from time zero to infinity were comparable indicated by geometric mean ratios (90%CI) of 0.85 (0.53-1.37) and 1.17 (0.73-1.85), respectively. Four transient and mild AEs in three subjects with severe RI were reported; three AEs were considered not related to ACT-1014-6470. These results support the use of ACT-1014-6470 in subjects with mild to severe RI without the need of dose adjustment." @default.
- W4307343405 created "2022-10-31" @default.
- W4307343405 creator A5051256127 @default.
- W4307343405 creator A5053860437 @default.
- W4307343405 creator A5058093690 @default.
- W4307343405 creator A5072257915 @default.
- W4307343405 creator A5086100533 @default.
- W4307343405 date "2022-10-26" @default.
- W4307343405 modified "2023-10-16" @default.
- W4307343405 title "Effect of Severe Renal Impairment on Pharmacokinetics, Safety, and Tolerability of ACT‐1014‐6470, a Novel Oral Complement Factor 5a Receptor 1 Antagonist" @default.
- W4307343405 cites W2043709342 @default.
- W4307343405 cites W2055864845 @default.
- W4307343405 cites W2109982451 @default.
- W4307343405 cites W2123156974 @default.
- W4307343405 cites W2136648677 @default.
- W4307343405 cites W2293035635 @default.
- W4307343405 cites W2784050872 @default.
- W4307343405 cites W2808907424 @default.
- W4307343405 cites W2942790287 @default.
- W4307343405 cites W3215631612 @default.
- W4307343405 cites W4281256391 @default.
- W4307343405 doi "https://doi.org/10.1002/cpdd.1184" @default.
- W4307343405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36285509" @default.
- W4307343405 hasPublicationYear "2022" @default.
- W4307343405 type Work @default.
- W4307343405 citedByCount "0" @default.
- W4307343405 crossrefType "journal-article" @default.
- W4307343405 hasAuthorship W4307343405A5051256127 @default.
- W4307343405 hasAuthorship W4307343405A5053860437 @default.
- W4307343405 hasAuthorship W4307343405A5058093690 @default.
- W4307343405 hasAuthorship W4307343405A5072257915 @default.
- W4307343405 hasAuthorship W4307343405A5086100533 @default.
- W4307343405 hasConcept C112705442 @default.
- W4307343405 hasConcept C126322002 @default.
- W4307343405 hasConcept C126894567 @default.
- W4307343405 hasConcept C159641895 @default.
- W4307343405 hasConcept C170493617 @default.
- W4307343405 hasConcept C197934379 @default.
- W4307343405 hasConcept C2776885963 @default.
- W4307343405 hasConcept C2778375690 @default.
- W4307343405 hasConcept C71924100 @default.
- W4307343405 hasConcept C90924648 @default.
- W4307343405 hasConcept C98274493 @default.
- W4307343405 hasConceptScore W4307343405C112705442 @default.
- W4307343405 hasConceptScore W4307343405C126322002 @default.
- W4307343405 hasConceptScore W4307343405C126894567 @default.
- W4307343405 hasConceptScore W4307343405C159641895 @default.
- W4307343405 hasConceptScore W4307343405C170493617 @default.
- W4307343405 hasConceptScore W4307343405C197934379 @default.
- W4307343405 hasConceptScore W4307343405C2776885963 @default.
- W4307343405 hasConceptScore W4307343405C2778375690 @default.
- W4307343405 hasConceptScore W4307343405C71924100 @default.
- W4307343405 hasConceptScore W4307343405C90924648 @default.
- W4307343405 hasConceptScore W4307343405C98274493 @default.
- W4307343405 hasIssue "2" @default.
- W4307343405 hasLocation W43073434051 @default.
- W4307343405 hasLocation W43073434052 @default.
- W4307343405 hasOpenAccess W4307343405 @default.
- W4307343405 hasPrimaryLocation W43073434051 @default.
- W4307343405 hasRelatedWork W2037576960 @default.
- W4307343405 hasRelatedWork W2074207917 @default.
- W4307343405 hasRelatedWork W2285479586 @default.
- W4307343405 hasRelatedWork W2396178441 @default.
- W4307343405 hasRelatedWork W2400700397 @default.
- W4307343405 hasRelatedWork W4205587618 @default.
- W4307343405 hasRelatedWork W4253098345 @default.
- W4307343405 hasRelatedWork W4296087748 @default.
- W4307343405 hasRelatedWork W4366822339 @default.
- W4307343405 hasRelatedWork W4379260174 @default.
- W4307343405 hasVolume "12" @default.
- W4307343405 isParatext "false" @default.
- W4307343405 isRetracted "false" @default.
- W4307343405 workType "article" @default.